# Biomat USA Inc – FDA Inspection, Apr 27, 2017

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/3cdb9466-f919-4fde-b8dd-cd2b15dc5e86
Source feed: FDA_Inspections

> FDA inspection 1014325 of Biomat USA Inc, April 27, 2017. Classification: No Action Indicated (NAI). 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1014325
- Company Name: Biomat USA Inc
- Inspection Date: 2017-04-27
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1249375 - 2024-08-14
- FDA Inspection 1096834 - 2019-06-25
- FDA Inspection 921477 - 2015-04-09
- FDA Inspection 831630 - 2013-04-10
- FDA Inspection 722294 - 2011-04-28

## Related Officers

- [Bradley E. Benasutti](https://www.keypedia.com/people/bradley-e-benasutti/7a03a364-ad6f-4a80-8504-3fbddc50af58)

Company: https://www.keypedia.com/companies/biomat-usa-inc/1e88dca4-643e-4e48-981c-9b5d30c64ad6

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d